Osteoporosis: overview and pipeline.

Simple coating with fibronectin fragment enhances stainless steel screw osseointegration in healthy and osteoporotic rats. Biomaterials (2015) 0.82

Correlation of X-ray vector radiography to bone micro-architecture. Sci Rep (2014) 0.79

Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway. Acta Pharmacol Sin (2012) 0.79

Pegloticase. Nat Rev Drug Discov (2011) 1.76

Vemurafenib. Nat Rev Drug Discov (2011) 1.68

Tetrabenazine. Nat Rev Drug Discov (2009) 1.60

Eculizumab. Nat Rev Drug Discov (2007) 1.56

Dabigatran etexilate. Nat Rev Drug Discov (2008) 1.41

Sipuleucel-T. Nat Rev Drug Discov (2010) 1.37

Tocilizumab. Nat Rev Drug Discov (2009) 1.36

Denosumab. Nat Rev Drug Discov (2010) 1.31

Everolimus. Nat Rev Drug Discov (2009) 1.29

Asenapine. Nat Rev Drug Discov (2009) 1.21

Tolvaptan. Nat Rev Drug Discov (2009) 1.13

Febuxostat. Nat Rev Drug Discov (2009) 1.12

Ivacaftor. Nat Rev Drug Discov (2012) 1.12

Golimumab. Nat Rev Drug Discov (2009) 1.11

Lapatinib. Nat Rev Drug Discov (2007) 1.10

Lacosamide. Nat Rev Drug Discov (2008) 1.09

Control of malaria. Nat Rev Drug Discov (2010) 1.08

Crizotinib. Nat Rev Drug Discov (2011) 1.05

Plerixafor. Nat Rev Drug Discov (2009) 1.04

Brentuximab vedotin. Nat Rev Drug Discov (2012) 1.04

Pazopanib. Nat Rev Drug Discov (2010) 1.02

Ustekinumab. Nat Rev Drug Discov (2009) 1.02

Certolizumab pegol. Nat Rev Drug Discov (2008) 0.98

Ruxolitinib. Nat Rev Drug Discov (2012) 0.96

Telavancin. Nat Rev Drug Discov (2009) 0.94

Ecallantide. Nat Rev Drug Discov (2010) 0.91

Prasugrel. Nat Rev Drug Discov (2009) 0.90

Romiplostim. Nat Rev Drug Discov (2008) 0.86

Alvimopan. Nat Rev Drug Discov (2008) 0.86

Roflumilast. Nat Rev Drug Discov (2010) 0.85

Velaglucerase alfa. Nat Rev Drug Discov (2010) 0.85

Pirfenidone. Nat Rev Drug Discov (2011) 0.83

Belimumab. Nat Rev Drug Discov (2011) 0.83

Pasireotide. Nat Rev Drug Discov (2012) 0.81

Ofatumumab. Nat Rev Drug Discov (2010) 0.81

Inhaled aztreonam. Nat Rev Drug Discov (2010) 0.81

Rheumatoid arthritis market. Nat Rev Drug Discov (2009) 0.79

Bendamustine. Nat Rev Drug Discov (2008) 0.79

Ambrisentan. Nat Rev Drug Discov (2007) 0.75